Gieseck Richard L

Richard L. Gieseck received the B.S. degree in biomedical engineering from Purdue University, West Lafayette, IN, USA, in 2012. He is currently pursuing the Ph.D. degree at the University of Cambridge, Cambridge, U.K., where he studies under a full NIH Fellowship, and maintains a joint appointment with the National Institute of Allergy and Infectious Diseases. He is investigating the use of human induced pluripotent stem cells (hiPSCs) to create patient specific, in vitro models of hepatic fibrosis for high-throughput pharmaceutical testing. He is researching the use of hiPSC-derived hepatocytes to ameliorate fibrosis within patients exhibiting late-stage cirrhosis with NIH, Bethesda, MD, USA.